bronchitis: An acute or chronic inflammatory process affecting the bronchi. [database_cross_reference: NCIT:C2911]
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1559 |
4. Check minimum number of eventsNone |
1559 |
5. Include endpointsNone |
1559 |
6. Filter based on genotype QC (FinnGen only) |
1516 |
Control definitions (FinnGen only)
- Control exclude
- J10_LOWCHRON
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- J40-J47
- Name in latin
- Bronchitis chronica non specificata
Similar endpoints
↥List of similar endpoints to
Unspecified chronic bronchitis
based on the number of shared cases.
Similar with more cases:
- Chronic lower respiratory diseases
- Excluding asthma or asthma-COPD overlap
- COPD differential diagnosis
- ILD differential diagnosis
- Diseases of the respiratory system
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 18442 | 6735 | 11129 |
| Only index persons | 8641 | 4155 | 4486 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.28 | 0.19 | 0.31 |
| Only index persons | 0.16 | 0.15 | 0.17 |
| Median age at first event (years) | |||
| Whole population | 61.97 | 59.69 | 63.16 |
| Only index persons | 54.81 | 54.34 | 55.24 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1516 | 560 | 956 |
| Unadjusted period prevalence (%) | 0.35 | 0.20 | 0.44 |
| Median age at first event (years) | 57.26 | 53.68 | 59.35 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1559
- Matched controls
- 15586
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R03BB01
ATC
ipratropium bromide; inhalant
19.8
320.6
261
157
R03BB04
ATC
tiotropium bromide; inhalant
29.9
307.7
435
199
J45.9
ICD-10 Finland
Asthma, unspecified
45.2
307.7
489
156
J45.1
ICD-10 Finland
Nonallergic asthma
134.6
307.7
179
15
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
307.7
595
*
R03AK03
ATC
[U] fenoterol and ipratropium bromide
18.1
307.7
342
238
R03AK06
ATC
salmeterol and fluticasone; inhalant
14.9
307.7
422
378
J45.0
ICD-10 Finland
Predominantly allergic asthma
99.6
307.7
169
19
49109
ICD-8 Finland
Chronic bronchitis, Unspecified
+∞
307.7
341
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
154.8
307.7
214
16
J42
ICD-10 Finland
Unspecified chronic bronchitis
2362.8
307.7
1060
14
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
127.0
307.7
228
21
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
91.8
307.7
522
85
R03AC12
ATC
salmeterol; inhalant
70.7
307.7
198
32
R03DA04
ATC
theophylline; systemic, rectal
19.5
307.7
314
199
R03AC02
ATC
salbutamol; inhalant
7.0
305.2
1084
3832
R03BA01
ATC
beclometasone; inhalant
10.6
288.2
358
428
R03BA05
ATC
fluticasone; inhalant
8.4
278.2
435
688
R03BA02
ATC
budesonide; inhalant
8.8
274.6
404
595
UGC12
NOMESCO Finland
Flexible bronchoscopy
8.9
249.3
354
497
R03DC03
ATC
montelukast; oral
9.3
247.7
337
449
R03AK07
ATC
formoterol and budesonide; inhalant
6.7
218.2
421
818
H02AB06
ATC
prednisolone; systemic
4.9
206.9
969
3931
4919X
ICD-9 Finland
Chronic bronchitis, Unspecified chronic bronchitis
+∞
199.3
187
*
R03AC13
ATC
formoterol; inhalant
28.9
199.0
135
51
R96
ICPC
Asthma
14.5
175.6
164
125
J45
ICD-10 Finland
Asthma
14.9
173.7
160
119
R03AC03
ATC
terbutaline; inhalant
6.4
149.0
275
501
R03AK08
ATC
formoterol and beclometasone; inhalant
31.3
147.5
97
33
J47
ICD-10 Finland
Bronchiectasis
1535.3
145.1
139
*
R03BA08
ATC
ciclesonide; inhalant
9.0
132.4
173
214
R95
ICPC
Chron obstructive pulmonary disease
31.6
128.4
84
28
H02AB04
ATC
methylprednisolone; systemic
4.8
127.4
345
878
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
278.6
127.1
128
5
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
4.1
124.3
444
1390
J96.1
ICD-10 Finland
Chronic respiratory failure
19.0
119.1
95
53
J01MA14
ATC
moxifloxacin; systemic
5.5
116.5
254
536
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
+∞
106.5
101
*
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
17.3
104.4
87
53
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
8.5
103.0
139
178
R05
ICD-10 Finland
Cough
3.6
102.3
426
1461
J45.8
ICD-10 Finland
Mixed asthma
514.1
98.6
97
*
R04.2
ICD-10 Finland
Haemoptysis
7.7
95.2
139
195
XG474
NOMESCO Finland
Exhalation nntrogen oxide
20.3
90.8
70
36
49300
ICD-8 Finland
Asthma, bronchiale
+∞
89.4
85
*
H02AB07
ATC
prednisone; oral
3.8
87.4
309
941
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.2
85.9
133
199
R03BB02
ATC
oxitropium bromide; inhalant
28.1
84.0
57
21
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
117.9
82.8
89
8
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
82.8
634
3043
R06.0
ICD-10 Finland
Dyspnoea
3.0
81.6
513
2213
J01FA06
ATC
roxithromycin; oral
2.7
80.4
710
3653
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
21.1
75.2
57
28
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
9.6
74.9
90
99
R06.2
ICD-10 Finland
Wheezing
7.9
74.4
105
141
R03AK11
ATC
formoterol and fluticasone; inhalant
20.7
73.4
56
28
J01AA02
ATC
doxycycline; systemic
3.1
71.4
1255
8885
J01FA09
ATC
clarithromycin; systemic
2.8
71.2
498
2249
XG410
NOMESCO Finland
Flow-volume spirometry
7.6
67.5
98
136
49099
ICD-8 Finland
Bronchitis, unspecified
+∞
67.2
64
*
J46
ICD-10 Finland
Status asthmaticus
236.8
66.8
68
*
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
+∞
65.0
62
*
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
+∞
64.0
61
*
R03DC01
ATC
zafirlukast; oral
23.7
63.7
46
20
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.6
62.1
234
735
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
18.0
60.3
49
28
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.7
54.2
77
104
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
100.3
53.2
58
6
49104
ICD-8 Finland
Chronic bronchitis, Cum emphysemate
+∞
51.3
49
*
R03DA05
ATC
aminophylline; systemic, rectal
15.6
50.4
44
29
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
7.6
49.9
72
99
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.0
49.0
251
942
R05CB01
ATC
acetylcysteine; inhalant, oral
8.6
48.6
63
76
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.2
48.0
734
4530
J01MA12
ATC
levofloxacin; systemic
2.5
47.6
369
1709
R02
ICPC
Shortness of breath/dyspnoea
3.1
47.5
223
796
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
5.4
46.7
95
185
J01FA10
ATC
azithromycin; systemic
2.1
45.1
750
4747
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
157.8
44.0
46
*
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.1
42.5
122
315
R01AD08
ATC
fluticasone; nasal
2.3
42.5
391
1946
R03BC03
ATC
nedocromil; inhalant
3.9
40.8
125
338
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
8.1
40.6
55
70
49101
ICD-8 Finland
Chronic bronchitis, Nonpurulenta (simplex)
+∞
39.7
38
*
TGC00
NOMESCO Finland
Bronchial lavation
6.5
37.8
63
101
48609
ICD-8 Finland
Pneumonia, unspecified
8.0
36.7
50
64
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.1
36.3
444
2460
J41.0
ICD-10 Finland
Simple chronic bronchitis
49.0
35.8
43
9
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.9
35.4
108
291
J01FA15
ATC
telithromycin; oral
3.1
35.3
155
529
GD1AD
NOMESCO Finland
Thorax CT examination
3.8
34.9
111
308
R01AD09
ATC
mometasone; nasal
2.0
34.7
568
3487
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
46.7
33.9
41
9
J01DA01
ATC
[U] cefalexin
1.9
33.6
961
7076
51899
ICD-8 Finland
Bronchiectasis
+∞
33.4
32
*
G47.3
ICD-10 Finland
Sleep apnoea
2.2
32.7
323
1636
J43.9
ICD-10 Finland
Emphysema, unspecified
63.1
32.1
37
6
SPAT1059
SPAT
Spirometry at the office
4.5
32.1
80
185
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
+∞
31.3
30
*
XQ800
NOMESCO Finland
Prick test
3.9
30.4
92
246
A01AB09
ATC
miconazole; local oral
2.8
30.2
160
605
J20
ICD-10 Finland
Acute bronchitis
2.9
29.9
153
568
R05DA20
ATC
opium alkaloids and derivatives - combinations
2.0
29.5
381
2132
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.7
28.9
67
146
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.6
28.7
99
290
R03DA54
ATC
theophylline, combinations excl. psycholeptics; systemic
6.6
28.6
46
71
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.5
28.4
100
297
C03CA01
ATC
furosemide; systemic
1.8
28.3
632
4226
A02BC01
ATC
omeprazole; systemic
1.9
28.1
457
2761
R05CB02
ATC
bromhexine; systemic
5.5
27.7
54
101
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.9
27.6
542
3476
R29
ICPC
Respiratory symptom/complaint other
3.4
27.4
104
324
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
6.9
27.2
42
62
A02BA02
ATC
ranitidine; systemic
2.0
26.9
359
2024
N02AX02
ATC
tramadol; systemic, rectal
1.8
26.2
650
4460
J37.0
ICD-10 Finland
Chronic laryngitis
4.5
25.7
64
148
48509
ICD-8 Finland
Bronchopneumonia, unspecified
8.4
25.3
33
40
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
24.9
496
3175
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
24.8
671
4699
R03AC04
ATC
fenoterol; inhalant
254.0
24.7
25
*
R05
ICPC
Cough
2.0
24.6
306
1676
1240
FHL
Bronchoscopy
5.5
24.6
48
90
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.4
24.0
60
139
R05FB02
ATC
cough suppressants and expectorants; systemic
1.8
24.0
580
3923
R03CC02
ATC
salbutamol; systemic
4.6
24.0
58
131
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.1
23.8
50
100
A02BC05
ATC
esomeprazole; systemic
1.8
23.6
570
3850
J32.4
ICD-10 Finland
Chronic pansinusitis
9.8
23.3
27
28
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.0
23.0
103
354
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
4.7
23.0
54
119
49102
ICD-8 Finland
Chronic bronchitis, Purulenta
+∞
23.0
22
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.1
22.9
264
1404
XG460
NOMESCO Finland
Short time oxymetry
5.4
22.8
45
85
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
32.8
22.4
29
9
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
3.7
22.2
72
202
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.9
22.2
65
170
Y0499
ICD-8 Finland
Investigation of respiratory system
6.2
22.1
38
63
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
+∞
21.9
21
*
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
20.4
21.7
32
16
SPAT1058
SPAT
PEF monitoring instruction
3.0
21.3
98
342
4940A
ICD-9 Finland
Bronchiectasis[BRONCHIECTASIAE]
+∞
20.9
20
*
A07AA02
ATC
nystatin; oral
2.9
20.7
100
359
46699
ICD-8 Finland
Acute bronchitis and bronchiolitis
7.6
20.4
29
39
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.4
20.4
147
645
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
6.3
20.2
34
55
A02BC03
ATC
lansoprazole; oral
1.7
20.0
439
2860
4910A
ICD-9 Finland
Chronic bronchitis, Simple chronic bronchitis
+∞
19.8
19
*
4900A
ICD-9 Finland
Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]
+∞
19.8
19
*
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
202.4
19.6
20
*
R06AE07
ATC
cetirizine; oral
1.7
19.5
507
3457
R01AD11
ATC
triamcinolone; nasal
2.5
19.1
122
506
J02AC01
ATC
fluconazole; systemic
1.7
18.9
439
2898
R78
ICPC
Acute bronchitis/bronchiolitis
5.4
18.8
37
70
R03AC18
ATC
indacaterol; inhalant
70.7
18.7
21
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
18.7
427
2804
A02BC02
ATC
pantoprazole; systemic
1.6
18.4
929
7435
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
5.0
18.3
39
79
R28
ICPC
Limited function/disability (R)
6.7
18.3
29
44
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.5
18.3
117
485
XG466
NOMESCO Finland
Sleep oxymetry
4.2
18.2
48
116
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
18.1
404
2634
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
6.5
17.9
29
45
R01AD58
ATC
fluticasone, combinations; nasal
1.9
17.9
235
1303
R81
ICPC
Pneumonia
3.5
17.6
62
184
R05FA02
ATC
opium derivatives and expectorants; systemic
1.6
17.4
547
3888
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.5
17.4
109
448
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
17.2
299
1810
J01FA01
ATC
erythromycin; systemic
2.1
17.2
165
815
J31.0
ICD-10 Finland
Chronic rhinitis
2.6
17.2
105
426
A01AB04
ATC
amphotericin B; local oral
2.8
17.2
89
332
J01DA06
ATC
[U] cefuroxime
2.0
17.1
204
1093
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
17.0
163
805
UDC00
NOMESCO Finland
Ear microscopy
2.4
16.9
115
491
WZC30
NOMESCO Finland
Teaching
2.0
16.9
210
1141
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
+∞
16.7
16
*
SPAT1263
SPAT
Sampling
1.6
16.4
547
3932
R03CC03
ATC
terbutaline; systemic
6.4
16.3
27
43
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
4.7
16.1
37
80
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
11.8
16.1
29
25
N05CD07
ATC
temazepam; oral
1.9
16.0
244
1417
C01AA05
ATC
digoxin; systemic
1.9
15.9
216
1208
N05CF01
ATC
zopiclone; oral
1.6
15.7
511
3643
R04
ICPC
Breathing problem other
3.4
15.7
57
173
XG405
NOMESCO Finland
Education on PEF monitoring
13.1
15.7
27
21
J01DC02
ATC
cefuroxime; systemic
2.8
15.6
78
286
R01AD12
ATC
fluticasone furoate; nasal
1.7
15.5
308
1934
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
15.4
294
1825
J01DA09
ATC
[U] cefadroxil
1.7
15.2
359
2361
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
15.1
104
446
N03AX12
ATC
[U] gabapentin; oral
1.9
15.0
217
1239
Z72.0
ICD-10 Finland
Tobacco use
4.4
14.5
36
83
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
5.5
14.5
28
52
R03BB07
ATC
umeclidinium bromide; inhalant
27.4
14.3
19
7
A02BA03
ATC
famotidine; systemic
2.6
14.2
81
318
N03AX16
ATC
[U] pregabalin
1.7
14.2
300
1913
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.1
14.2
59
195
R06AX13
ATC
loratadine; oral
2.0
14.2
159
832
R74
ICPC
Upper respiratory infection acute
1.7
14.1
300
1914
J01FF01
ATC
clindamycin; systemic
1.6
14.1
354
2359
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
12.1
14.1
25
21
P01AB01
ATC
metronidazole; oral, rectal
1.6
13.9
490
3539
N05BA01
ATC
diazepam; systemic, rectal
1.9
13.9
193
1086
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
6.5
13.7
22
34
R51.80
ICD-10 Finland
Headache
1.9
13.6
177
974
GD1AA, ,
SPAT
2.2
13.6
125
607
4911A
ICD-9 Finland
Chronic bronchitis, Mucopurulent chronic bronchitis
+∞
13.6
13
*
N05BA04
ATC
oxazepam; oral
1.6
13.4
364
2469
C07AB07
ATC
bisoprolol; oral
1.5
13.4
741
5878
E66.00
ICD-10 Finland
Metabolic syndrome
2.6
13.1
74
289
M03BC51
ATC
orphenadrine, combinations; systemic
1.6
13.0
322
2135
Y3409
ICD-8 Finland
Follow-up examination of illness, accident or surgery, Treated inactive pulmonary tuberculosis
19.2
12.9
19
10
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
22.7
12.9
18
8
J01CA04
ATC
amoxicillin; systemic
1.5
12.9
1041
8890
J01MA02
ATC
ciprofloxacin; systemic
1.5
12.7
572
4336
R06AX27
ATC
desloratadine; oral
1.7
12.7
268
1703
C08DA01
ATC
verapamil; systemic
2.5
12.6
81
337
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
+∞
12.5
12
*
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
+∞
12.5
12
*
49309
ICD-8 Finland
Asthma, Unspecified
+∞
12.5
12
*
R09.3
ICD-10 Finland
Abnormal sputum
5.1
12.4
26
52
R05DA01
ATC
ethylmorphine; oral
2.2
12.4
113
546
ZY010
NOMESCO Finland
Hospital outpatient
2.8
12.4
60
216
R01BA52
ATC
pseudoephedrine, combinations; oral
1.6
12.4
339
2299
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
4.5
12.4
30
68
N06AA09
ATC
amitriptyline; systemic
2.0
12.4
139
727
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.5
12.3
425
3043
N06AX21
ATC
duloxetine; oral
2.0
12.2
136
709
A03CA02
ATC
clidinium and psycholeptics; oral
2.2
12.2
102
477
I42.0
ICD-10 Finland
Dilated cardiomyopathy
3.1
12.1
50
165
M54.5
ICD-10 Finland
Low back pain
1.5
12.0
408
2907
SPAT1257
SPAT
Teaching of medicine inhalation technique
3.5
11.7
39
112
A02BA04
ATC
nizatidine; systemic
2.0
11.6
136
721
Q32.21
ICD-10 Finland
Secondary congenital bronchomalacia
65.4
11.6
13
*
L03
ICPC
Low back symptom/complaint
1.6
11.6
309
2080
UJF32
NOMESCO Finland
Coloscopy
1.6
11.6
355
2470
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
3.3
11.5
43
133
R05CB03
ATC
carbocisteine; oral
3.2
11.4
44
139
R01AD05
ATC
budesonide; nasal
2.3
11.4
89
404
N06AA12
ATC
doxepin; systemic
2.3
11.3
86
386
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.7
11.3
35
96
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.0
11.2
50
172
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
3.1
11.2
47
156
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.2
11.2
90
414
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
25.2
11.1
15
6
N06AB04
ATC
citalopram; systemic
1.6
11.1
277
1832
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.1
11.1
45
147
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
10.9
312
2132
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.6
10.9
60
232
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
10.9
454
3368
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
12.0
10.8
19
16
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
8.9
10.8
22
25
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.0
10.7
127
677
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
5.6
10.7
20
36
R01AD01
ATC
beclometasone; nasal
1.8
10.6
171
1005
J01DA08
ATC
[U] cefaclor
2.1
10.5
106
533
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
14.3
10.5
17
12
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
10.5
131
711
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
10.5
369
2640
J43.8
ICD-10 Finland
Other emphysema
+∞
10.4
10
*
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.8
10.4
50
180
R06.5
ICD-10 Finland
Mouth breathing
2.0
10.4
106
536
A06AD11
ATC
lactulose; oral
1.6
10.0
278
1883
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
9.9
112
587
R52.2
ICD-10 Finland
Other chronic pain
2.8
9.9
49
179
R03AL11
ATC
formoterol, glycopyrronium bromide and budesonide; inhalant
26.2
9.8
13
5
J01EA01
ATC
trimethoprim; systemic
1.5
9.8
352
2525
WX723
NOMESCO Finland
CPAP therapy
2.7
9.7
52
198
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.0
9.7
110
577
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
9.7
525
4077
R10.0
ICD-10 Finland
Acute abdomen
2.8
9.6
46
165
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
2.0
9.6
109
572
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
11.4
9.6
17
15
ZXE00
NOMESCO Finland
One hour or less
1.4
9.6
499
3847
78310
ICD-8 Finland
Symptoms referable to respiratory system, Haemoptysis
10.1
9.5
18
18
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.2
9.5
76
349
M48.0
ICD-10 Finland
Spinal stenosis
1.7
9.5
177
1084
C08DB01
ATC
diltiazem; oral
1.9
9.5
113
604
N06AX11
ATC
mirtazapine; oral
1.5
9.4
408
3038
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
8.1
9.3
20
25
51925
ICD-8 Finland
Other diseases of respiratory system, Infiltratio pulmonis NUD
8.1
9.3
20
25
E66.01
ICD-10 Finland
Obesity due to excess calories
2.1
9.3
84
405
A03
ICPC
Fever
1.7
9.2
161
970
R05DB20
ATC
other cough suppressants - combinations
2.2
9.1
76
355
J15.8
ICD-10 Finland
Other bacterial pneumonia
7.8
9.1
20
26
UDM02
NOMESCO Finland
Sinoscopy
3.6
9.1
29
81
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
9.1
54
217
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
9.1
350
2543
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
15.7
9.0
14
9
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
9.0
216
1414
C01DA14
ATC
isosorbide mononitrate; oral
1.5
8.9
324
2327
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.2
8.8
71
327
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.5
8.8
30
88
R13
ICD-10 Finland
Dysphagia
2.0
8.7
97
506
D07AC13
ATC
mometasone; topical
1.5
8.7
352
2579
A01AB10
ATC
natamycin; local oral
2.8
8.7
42
152
4130X
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]
2.4
8.6
60
260
I50.0
ICD-10 Finland
Congestive heart failure
1.7
8.6
147
879
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.7
8.6
46
176
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
8.6
79
385
48601
ICD-8 Finland
More specifically, unspecified pneumonia and the pleural irritation caused by it
9.0
8.5
17
19
J98.1
ICD-10 Finland
Pulmonary collapse
9.0
8.5
17
19
GX1E5, ,
SPAT
9.0
8.5
17
19
R03BB06
ATC
glycopyrronium bromide; inhalant
27.7
8.5
11
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
8.5
215
1425
G44.2
ICD-10 Finland
Tension-type headache
1.8
8.4
139
822
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.6
8.4
46
178
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
3.0
8.4
36
122
348
Kela drug reimbursment
Roflumilast
+∞
8.3
8
*
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
3.1
8.3
34
112
R11
ICD-10 Finland
Nausea and vomiting
1.9
8.3
112
624
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.3
8.2
64
291
M04AA01
ATC
allopurinol; systemic
1.6
8.2
222
1494
S82.4
ICD-10 Finland
Fracture of fibula alone
3.6
8.1
26
73
4660A
ICD-9 Finland
Acute bronchitis and bronchiolitis, Acute bronchitis
4.6
8.1
19
42
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
3.3
8.1
29
88
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
2.7
8.1
43
164
R06AE09
ATC
levocetirizine; oral
1.8
8.0
128
750
R03BA07
ATC
mometasone; inhalant
10.1
8.0
15
15
R05DB05
ATC
pentoxyverine; oral, rectal
2.4
8.0
54
231
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.6
8.0
26
74
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
8.0
63
289
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.1
7.9
76
376
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
7.9
144
876
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
7.9
123
716
A03FA02
ATC
cisapride; oral, rectal
1.8
7.9
114
649
R24
ICPC
Haemoptysis
7.8
7.9
17
22
SPAT1260
SPAT
Consultation of another employee
1.6
7.9
212
1424
E66.9
ICD-10 Finland
Obesity, unspecified
2.8
7.8
38
138
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.4
7.8
27
80
J01CA02
ATC
pivampicillin; oral
2.7
7.8
40
150
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
7.7
412
3168
J41.8
ICD-10 Finland
Mixed simple and mucopurulent chronic bronchitis
45.2
7.7
9
*
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
5.9
7.7
20
34
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
7.7
507
4039
R49.01
ICD-10 Finland
Functional dysphonia
2.8
7.7
37
134
RK320, ,
NOMESCO Finland
4.5
7.7
18
40
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
7.6
186
1219
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.3
7.6
56
249
N06AX03
ATC
mianserin; oral
2.1
7.6
68
328
50609
ICD-8 Finland
Chronic laryngitis, Unspecified
25.1
7.6
10
*
WX780
NOMESCO Finland
Remote monitoring CPAP
2.4
7.6
50
212
7863A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Haemoptysis
7.1
7.5
17
24
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
4.3
7.5
19
45
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
3.7
7.5
23
63
D06
ICPC
Abdominal pain localized other
1.9
7.5
93
505
R05CA10
ATC
expectorants - combinations
2.9
7.5
33
114
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
7.4
120
706
M03BX02
ATC
tizanidine; oral
1.3
7.4
679
5685
A03DA02
ATC
pitofenone and analgesics; systemic
2.7
7.4
37
137
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
7.3
61
286
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
3.6
7.3
23
64
4939A
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]
+∞
7.3
7
*
49209
ICD-8 Finland
Emphysema, Unspecified
+∞
7.3
7
*
J43.2
ICD-10 Finland
Centrilobular emphysema
+∞
7.3
7
*
R03DX07
ATC
roflumilast; oral
+∞
7.3
7
*
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
2.9
7.3
32
110
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
7.2
363
2757
D07AA02
ATC
hydrocortisone; topical
1.6
7.2
162
1041
CA1TM
NOMESCO Finland
Calculation of intraocular lens power
2.8
7.2
34
122
SXC05
NOMESCO Finland
Other oral or dental procedure
2.1
7.2
63
302
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic
2.7
7.2
38
145
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.9
7.1
81
427
R07.3
ICD-10 Finland
Other chest pain
1.7
7.1
132
808
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.5
7.1
201
1365
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
7.1
495
3971
5110B
ICD-9 Finland
Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]
8.8
7.0
14
16
D07XC01
ATC
betamethasone; topical
1.6
7.0
159
1024
L04AA06
ATC
mycophenolic acid; systemic
3.5
7.0
23
66
Y0399
ICD-8 Finland
Investigation of circulatory system
3.3
7.0
25
76
Z01.9
ICD-10 Finland
Special examination, unspecified
2.0
7.0
75
388
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
6.9
289
2122
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
7.6
6.9
15
20
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.3
6.9
48
209
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
3.6
6.9
22
62
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
6.8
446
3535
C05AA08
ATC
fluocortolone; rectal, topical
1.6
6.8
167
1096
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
6.7
6.8
16
24
M01AE02
ATC
naproxen; oral, rectal
1.3
6.8
670
5645
S01GX01
ATC
cromoglicic acid; ophthalmic
1.6
6.8
173
1146
L30.3
ICD-10 Finland
Infective dermatitis
2.5
6.8
41
167
L04AX01
ATC
azathioprine; systemic
2.3
6.8
47
204
WX199
NOMESCO Finland
Other local analgesia
2.3
6.8
49
217
R03DA74
ATC
theophylline, combinations with psycholeptics; systemic
40.2
6.8
8
*
R03BB05
ATC
aclidinium bromide; inhalant
40.2
6.8
8
*
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.9
6.8
30
104
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
6.7
134
835
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
16.8
6.7
10
6
N06AG02
ATC
moclobemide; oral
2.2
6.7
53
243
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
6.7
201
1381
51900
ICD-8 Finland
Other diseases of respiratory system, Atelectasis pulmonis
22.6
6.7
9
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
6.7
445
3537
Z00.8
ICD-10 Finland
Other general examinations
1.8
6.7
89
495
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
6.7
113
675
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
5.5
6.6
18
33
50300
ICD-8 Finland
Chronic sinusitis, Maxillaris cum empyemate
5.9
6.6
17
29
R50.9
ICD-10 Finland
Fever, unspecified
1.5
6.6
192
1312
JN3AD
NOMESCO Finland
Abdominal CT examination
1.6
6.5
135
850
5645A
ICD-9 Finland
Functional digestive disorders, not elsewhere classified, Functional diarrhoea
10.1
6.5
12
12
N04BC05
ATC
pramipexole; oral
1.8
6.5
98
565
C03DA01
ATC
spironolactone; oral
1.6
6.5
171
1141
R52.9
ICD-10 Finland
Pain, unspecified
1.7
6.5
110
657
4289X
ICD-9 Finland
Heart failure, unspecified
3.7
6.5
20
55
J01MA01
ATC
ofloxacin; systemic
1.7
6.5
129
805
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.6
6.5
36
141
L01BA01
ATC
methotrexate; systemic
2.3
6.5
48
215
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.1
6.5
61
301
R06AX26
ATC
fexofenadine; oral
2.1
6.5
61
301
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
6.4
298
2228
J01GB01
ATC
tobramycin; inhalant, parenteral
70.1
6.4
7
*
J14
ICD-10 Finland
Pneumonia due to Haemophilus influenzae
70.1
6.4
7
*
GX1C5, ,
SPAT
70.1
6.4
7
*
R06AX22
ATC
ebastine; oral
1.6
6.4
160
1056
D07AC01
ATC
betamethasone; topical
1.4
6.4
428
3401
N05BA12
ATC
alprazolam; oral
1.7
6.4
119
730
L08
ICPC
Shoulder symptom/complaint
1.5
6.3
235
1685
4779A
ICD-9 Finland
Allergic rhinitis, Cause unspecified
8.2
6.3
13
16
C10AC01
ATC
colestyramine; oral
2.6
6.3
36
143
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
11.1
6.3
11
10
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.6
6.3
130
819
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
3.4
6.3
22
66
78330
ICD-8 Finland
Symptoms referable to respiratory system, Cough
18.1
6.3
9
5
4939B
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]
+∞
6.3
6
*
Q89.34
ICD-10 Finland
Cartagena syndrome (immotile cilia)
+∞
6.3
6
*
SPAT1262
SPAT
Handing over of treatment supplies
1.5
6.2
222
1579
ZYC01
NOMESCO Finland
Remote contact by phone
2.0
6.2
62
312
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
26.8
6.2
8
*
R03AC19
ATC
olodaterol
26.8
6.2
8
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
6.2
193
1335
WX882
NOMESCO Finland
High dependency care
2.4
6.2
39
162
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
6.2
116
712
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
6.2
159
1056
Z01.2
ICD-10 Finland
Dental examination
1.3
6.2
449
3609
D01
ICPC
Abdominal pain/cramps general
1.7
6.2
117
721
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
5.4
6.2
17
32
J96.0
ICD-10 Finland
Acute respiratory failure
3.3
6.1
22
67
T82
ICPC
Obesity
2.6
6.1
35
139
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
6.1
389
3062
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
6.1
208
1466
N03AX09
ATC
lamotrigine; oral
2.3
6.1
42
182
A02BC04
ATC
rabeprazole; oral
1.8
6.1
93
539
4019X
ICD-9 Finland
Essential hypertension, Unspecified
1.9
6.1
71
378
UJD02
NOMESCO Finland
Gastroscopy
2.0
6.1
66
343
T78.4
ICD-10 Finland
Allergy, unspecified
2.4
6.1
38
158
XFE00
NOMESCO Finland
Epicardial ultrasonography
2.4
6.1
38
158
L04AA01
ATC
[U] ciclosporin
3.6
6.0
19
53
M20.5
ICD-10 Finland
Other deformities of toe(s) (acquired)
6.7
6.0
14
21
SPAT1254
SPAT
Administration of medicine
1.5
6.0
191
1327
H02AB09
ATC
hydrocortisone; systemic
3.0
6.0
26
89
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
193
323
6.68
112.70
1.7
1.1
162.37
213.29
u/ml
0.26
180
286
53
13
42.16
87.79
1.5
1.1
2.38
0.17
u/ml
—
32
6
63
35
18.71
78.80
4.6
2.6
—
—
—
0
0
123
317
4.13
42.94
3.3
2.5
—
—
—
0
0
59
100
6.09
33.53
1.3
1.1
—
—
—
0
0
51
77
6.81
32.41
4.7
2.6
—
—
—
0
0
175
688
2.74
30.72
2.9
2.8
10.89
11.16
g/l
0.25
161
623
700
4754
1.86
30.44
7.4
5.8
25.71
27.02
%
2.45
658
4402
80
196
4.25
29.79
1.4
1.5
—
—
—
0
0
684
4675
1.82
28.60
7.1
5.5
59.27
57.83
%
2.36
645
4330
145
544
2.84
27.76
1.7
1.8
1.17
1.49
g/l
1.11
133
487
149
612
2.59
23.83
5.1
3.4
1.53
1.54
mmol/l
0.01
121
439
309
1814
1.88
19.90
2.4
1.7
—
—
—
0
0
116
465
2.61
19.45
2.4
1.8
—
—
—
0
0
762
5786
1.62
18.97
10.3
8.8
4.55
4.14
e9/l
4.47
689
5004
61
173
3.63
18.57
3.4
3.2
5.21
4.42
e9/l
1.29
61
173
62
183
3.49
17.78
3.5
3.7
60.48
59.07
%
0.30
62
183
327
2028
1.77
17.37
2.5
1.6
1.01
1.33
mg/l
1.71
244
1564
71
232
3.16
17.32
7.0
4.5
2.46
2.65
mmol/l
0.27
52
148
84
308
2.82
16.74
2.2
1.5
175.56
143.53
titre
—
9
17
59
177
3.42
16.52
1.4
1.3
—
—
—
0
0
64
203
3.24
16.40
3.3
2.3
16.29
16.01
%
0.22
34
94
102
433
2.45
15.17
2.1
1.7
—
—
—
0
0
51
153
3.41
14.30
2.1
1.4
—
—
—
0
0
32
69
4.71
14.02
1.7
1.6
—
—
—
0
0
54
186
2.97
12.10
1.2
1.1
—
—
—
0
0
199
1180
1.79
12.03
4.6
3.6
—
—
—
0
0
41
121
3.45
11.83
2.4
1.4
—
—
—
0
0
75
311
2.48
11.76
2.4
1.7
—
—
—
0
0
62
234
2.72
11.76
2.4
1.6
—
—
—
0
0
24
49
4.96
11.22
1.7
1.7
—
—
—
0
0
24
49
4.96
11.22
1.7
1.7
—
—
—
0
0
44
141
3.18
11.16
2.3
1.4
—
—
—
0
0
159
902
1.85
11.09
4.5
3.9
1.22
1.22
mmol/l
0.33
140
771
25
54
4.69
10.96
2.0
2.3
—
—
—
0
0
260
1711
1.62
10.64
1.6
1.4
2.53
2.53
g/l
0.02
177
997
668
5364
1.43
10.44
18.9
18.5
1.24
1.38
inr
4.16
300
1506
82
375
2.25
10.35
1.8
2.0
35.71
37.72
u/l
0.43
73
318
148
848
1.82
9.99
2.3
2.1
324.38
385.27
nmol/l
4.20
125
763
39
125
3.17
9.91
2.4
1.4
—
—
—
0
0
166
988
1.76
9.87
2.6
2.2
163.97
133.94
ug/g
0.55
126
785
232
1521
1.62
9.59
3.1
2.5
19.15
22.75
%
5.21
206
1297
44
156
2.87
9.42
1.6
1.6
—
—
—
0
0
44
156
2.87
9.42
1.6
1.6
—
—
—
0
0
241
1608
1.59
9.24
3.1
2.4
2.35
2.26
g/l
1.85
219
1468
888
7625
1.38
8.77
6.1
3.9
15.20
13.48
mm/h
2.29
833
6946
23
56
4.15
8.72
3.2
1.5
—
—
—
0
0
49
192
2.60
8.70
2.9
2.1
130.80
127.68
g/l
0.37
40
149
54
225
2.45
8.45
2.6
1.6
—
—
—
0
0
33
106
3.16
8.39
1.2
1.0
—
—
—
0
0
253
1745
1.54
8.34
3.1
2.4
11.45
12.65
umol/l
2.17
228
1607
444
3420
1.42
8.33
4.5
3.0
1530.64
1922.14
ng/l
0.87
394
2933
29
87
3.38
8.22
1.6
1.6
—
—
—
0
0
29
87
3.38
8.22
1.6
1.6
—
—
—
0
0
29
87
3.38
8.22
1.6
1.6
—
—
—
0
0
24
65
3.73
7.91
3.2
1.5
—
—
—
0
0
22
56
3.97
7.89
3.3
1.5
—
—
—
0
0
16
19
8.49
7.81
1.9
3.6
34.91
383.77
ug/l
0.45
16
19
745
6304
1.35
7.64
6.8
4.6
6.83
6.84
mmol/l
0.07
702
5924
25
73
3.46
7.40
1.2
1.1
4.19
1.52
u/ml
0.34
12
33
31
105
2.99
7.25
3.0
1.6
—
—
—
0
0
21
56
3.79
7.09
2.0
2.0
0.28
0.21
e9/l
0.74
16
50
421
3291
1.38
7.06
3.0
2.5
52.83
83.03
u/l
0.66
392
3021
21
58
3.66
6.75
1.9
2.0
478.07
557.86
e6/l
0.25
15
50
129
798
1.67
6.68
2.0
1.6
—
—
—
0
0
319
2404
1.41
6.59
3.2
2.7
6.33
5.12
e6/l
0.70
290
2173
657
5540
1.32
6.57
7.1
6.1
10.56
12.80
umol/l
7.04
623
5246
20
55
3.67
6.48
1.3
1.0
3.07
2.40
u/ml
0.09
11
23
212
1486
1.49
6.42
1.3
1.2
43.70
35.81
iu/ml
0.26
67
463
41
172
2.42
6.40
2.9
1.6
—
—
—
0
0
34
132
2.61
6.23
1.6
1.4
—
—
—
0
0
526
4328
1.32
6.15
5.3
3.8
69.02
62.46
ng/l
0.13
383
3208
34
133
2.59
6.14
1.6
1.4
—
—
—
0
0
184
1267
1.51
6.06
2.3
1.7
—
—
—
0
0
59
296
2.03
6.00
1.5
1.4
290.26
277.55
ug/g
0.14
27
173
185
2597
0.67
5.93
3.3
3.2
0.76
0.85
ug/l
0.79
131
1766
568
4746
1.31
5.89
5.8
4.7
34.73
34.96
g/l
0.41
525
4393
33
132
2.53
5.71
1.6
1.4
—
—
—
0
0
54
268
2.05
5.67
4.3
3.9
1.75
1.71
mg/l
0.13
47
245
14
24
5.87
5.53
1.3
1.4
—
—
—
0
0
29
112
2.62
5.40
1.3
1.5
—
—
—
0
0
199
1425
1.45
5.40
1.2
1.2
5.18
12.37
u/ml
1.64
82
539
149
1007
1.53
5.37
3.7
2.9
170.62
258.77
ng/l
2.11
132
915
626
5354
1.28
5.28
3.1
2.6
—
—
—
0
0
367
2924
1.33
5.24
2.6
2.1
2.99
3.00
mg/l
0.03
319
2440
33
138
2.42
5.23
3.0
1.6
—
—
—
0
0
228
1692
1.41
5.08
4.9
3.1
0.80
0.82
mmol/l
2.00
209
1580
15
41
3.68
4.93
1.1
1.0
0.18
0.87
u/ml
—
7
10
12
20
6.04
4.91
1.1
1.3
—
—
—
0
0
170
1204
1.46
4.89
9.3
7.2
1.84
0.84
mmol/l
2.88
133
929
177
1265
1.45
4.85
2.3
1.6
—
—
—
0
0
45
222
2.06
4.84
1.5
1.3
—
—
—
0
0
1068
11478
0.78
4.84
35.2
22.2
133.56
133.73
g/l
0.13
1046
11207
1067
11468
0.78
4.83
34.8
22.1
255.22
240.73
e9/l
9.22
1046
11069
91
1422
0.62
4.80
8.2
7.9
—
—
—
0
0
1068
11474
0.78
4.79
34.7
22.1
4.45
4.42
e12/l
0.88
1043
11037
169
1204
1.45
4.71
9.4
7.2
5.29
4.98
kpa
3.44
159
1143
81
488
1.70
4.70
2.8
1.9
1.51
2.95
ug/l
0.63
67
419
1068
11465
0.78
4.69
35.3
22.2
39.70
39.48
%
0.49
1018
10561
45
225
2.03
4.68
1.6
1.2
—
—
—
0
0
45
225
2.03
4.68
1.6
1.2
—
—
—
0
0
31
133
2.36
4.68
1.6
1.4
—
—
—
0
0
286
3598
0.75
4.63
4.2
4.4
22.58
22.04
%
0.22
139
1797
22
80
2.77
4.62
3.7
1.6
—
—
—
0
0
31
134
2.34
4.61
1.6
1.4
—
—
—
0
0
31
134
2.34
4.61
1.6
1.4
—
—
—
0
0
1070
11475
0.78
4.59
34.7
22.1
7.69
6.74
e9/l
2.14
1042
11034
630
5461
1.26
4.57
9.3
6.5
1.21
1.21
mmol/l
0.13
486
4590
168
1203
1.44
4.56
9.5
7.2
10.56
12.36
kpa
6.62
158
1144
350
2828
1.31
4.45
3.0
2.8
4020.13
7585.42
umol/l
0.87
304
2433
505
4292
1.26
4.28
3.3
2.7
133.89
152.30
ug/l
0.76
451
3883
308
2460
1.31
4.25
1.7
1.7
446.97
14997909.06
pmol/l
1.50
238
1987
13
29
4.51
4.24
1.5
1.3
—
—
—
0
0
20
73
2.76
4.19
1.4
1.4
101.40
93.66
umol/l
0.25
20
73
389
3211
1.28
4.18
3.6
3.2
32.80
36.20
u/l
0.58
362
3037
956
10344
0.80
4.16
5.4
5.0
2.65
2.66
mmol/l
0.14
847
9348
21
83
2.55
3.80
1.8
1.5
12.19
14.69
u/l
1.45
21
78
16
55
2.93
3.74
1.2
1.0
—
—
—
0
0
16
55
2.93
3.74
1.2
1.0
—
—
—
0
0
82
528
1.58
3.72
12.7
9.3
25.11
24.12
mmol/l
2.29
76
505
796
8730
0.82
3.71
27.2
17.9
15.58
15.15
%
1.08
777
8527
9
16
5.65
3.66
2.7
1.4
181.11
130.00
ng/l
—
9
16
174
1306
1.37
3.63
4.7
4.2
251.24
257.14
u/l
0.16
164
1216
269
2156
1.30
3.60
5.5
3.8
108.74
440.43
ng/l
4.57
192
1789
141
1024
1.41
3.58
6.4
3.4
2.40
1.65
mmol/l
1.83
122
822
97
658
1.51
3.51
1.9
1.4
—
—
—
0
0
147
1081
1.40
3.48
10.3
7.6
93.51
95.80
%
2.23
141
1039
10
22
4.57
3.43
1.4
2.1
—
—
—
0
0
40
701
0.56
3.35
1.8
1.8
—
—
—
0
0
137
1009
1.39
3.23
2.8
2.2
0.20
0.21
g/l
0.19
122
932
17
66
2.59
3.21
1.3
1.1
—
36.33
—
0
6
1037
11019
0.82
3.20
14.1
10.3
25.33
26.06
u/l
0.67
1001
10513
7
11
6.38
3.18
1.3
1.0
—
—
—
0
0
59
368
1.63
3.10
1.3
1.2
—
—
—
0
0
142
1060
1.37
3.09
3.0
2.4
8.57
7.12
ug/l
0.14
118
908
942
10083
0.83
3.06
5.0
4.5
4.54
4.54
mmol/l
0.02
841
9176
388
4495
0.82
2.96
5.3
5.1
2.50
4.58
ug/l
1.28
337
3962
47
280
1.70
2.95
2.4
3.1
0.79
0.80
nmol/l
0.06
35
214
12
37
3.26
2.93
2.1
1.7
—
—
—
0
0
12
37
3.26
2.93
2.1
1.7
—
—
—
0
0
33
178
1.87
2.87
1.5
1.2
45.46
10.34
u/ml
—
5
10
79
538
1.49
2.85
3.2
3.3
4.19
4.46
pmol/l
2.05
70
466
19
83
2.30
2.84
1.4
1.3
—
—
—
0
0
160
1239
1.32
2.76
1.6
1.4
—
—
—
0
0
393
3386
1.21
2.76
4.0
3.4
334.75
69.13
e6/l
0.42
324
2654
44
263
1.69
2.75
1.5
1.6
0.02
0.17
iu/ml
—
10
51
477
4194
1.20
2.70
2.7
2.2
78.48
78.58
nmol/l
0.03
431
3667
938
9994
0.85
2.67
4.9
4.4
1.41
1.43
mmol/l
1.10
831
9013
19
86
2.22
2.64
1.3
1.4
—
—
—
0
0
19
87
2.20
2.57
1.6
1.3
11.00
13.38
u/l
0.39
19
81
15
62
2.43
2.54
2.0
1.6
15.38
5.84
u/l
—
8
52
22
108
2.05
2.52
1.4
1.5
—
—
—
0
0
22
108
2.05
2.52
1.4
1.5
—
—
—
0
0
134
1027
1.33
2.50
6.6
3.4
6.00
5.69
kpa
3.34
129
991
11
37
2.99
2.49
2.2
1.7
—
—
—
0
0
233
1921
1.25
2.48
1.3
1.2
0.79
1.51
u/ml
1.63
60
504
318
2711
1.22
2.47
1.6
1.6
18.61
20.36
nmol/l
1.64
271
2280
126
959
1.34
2.47
2.0
2.9
66.32
66.28
g/l
0.02
115
860
907
9658
0.85
2.43
4.5
4.0
1.39
1.28
mmol/l
3.38
799
8640
953
10108
0.85
2.43
5.2
4.7
6.08
6.03
mmol/l
0.51
846
9001
39
234
1.68
2.43
1.5
1.2
—
17.31
—
0
13
43
265
1.64
2.43
2.0
1.7
—
—
—
0
0
286
2419
1.22
2.40
1.9
1.8
1148.21
1164.62
nmol/l
0.10
201
1788
884
8239
1.17
2.39
9.6
7.3
78.51
81.60
u/l
1.38
846
7667
549
4953
1.17
2.22
7.7
5.8
1.21
1.21
mmol/l
0.09
498
4466
35
211
1.67
2.17
6.8
5.2
514.92
329.48
iu/ml
0.28
13
33
422
3737
1.18
2.14
3.1
3.3
2.35
2.35
mmol/l
0.10
372
3238
380
3337
1.18
2.13
2.7
2.1
172.85
229.11
u/l
0.98
352
3119
22
116
1.91
2.11
1.5
1.5
6.11
6.54
mmol/l
0.42
22
109
693
6391
1.15
2.04
3.9
3.1
57.15
53.70
u/l
0.39
637
5886
36
223
1.63
2.03
1.5
1.2
10.17
12.68
u/ml
—
6
41
12
50
2.41
2.02
1.3
1.2
—
—
—
0
0
22
118
1.88
2.02
1.7
1.5
59.75
65.78
%
0.27
16
73
190
2280
0.81
2.00
5.2
4.2
1.02
1.02
kg/l
0.36
40
348
130
1030
1.29
1.96
3.5
2.5
67.61
67.22
e9/l
0.05
100
800
10
39
2.57
1.94
2.3
1.3
—
—
—
0
0
8
27
2.97
1.93
2.6
2.9
35387.50
39581.48
ug/l
—
8
27
19
99
1.93
1.90
2.0
1.7
—
—
—
0
0
304
2646
1.18
1.88
2.7
2.4
—
—
—
0
0
20
107
1.88
1.86
1.9
1.7
—
—
—
0
0
808
7573
1.14
1.80
4.4
3.7
15.08
14.92
pmol/l
1.08
720
6726
512
4658
1.15
1.78
2.1
2.0
94.36
93.33
pmol/l
0.16
266
2445
167
1381
1.23
1.77
3.0
2.4
1.78
1.75
%
0.16
142
1209
1047
10924
0.87
1.75
27.2
17.9
3.98
4.00
mmol/l
1.03
1017
10559
121
965
1.27
1.75
10.3
6.3
1.48
1.42
mmol/l
0.19
113
935
18
95
1.90
1.75
2.4
1.6
—
—
—
0
0
7
24
2.92
1.72
1.3
1.0
—
—
—
0
0
54
382
1.43
1.71
1.7
3.7
1.01
1.85
ratio
—
5
32
346
3074
1.16
1.66
3.9
3.3
0.64
0.49
e6/l
0.19
284
2402
7
25
2.81
1.65
1.4
1.3
—
—
—
0
0
11
49
2.25
1.63
2.1
2.5
497.55
1654.63
u/ml
1.38
11
49
1046
10892
0.88
1.62
27.1
17.8
139.26
139.67
mmol/l
5.19
1018
10541
17
91
1.88
1.60
1.1
1.1
—
—
—
0
0
20
113
1.78
1.60
1.5
1.3
266.00
279.42
pmol/l
0.11
20
99
22
128
1.73
1.60
2.1
2.6
12.50
23.01
mg/l
—
8
34
54
388
1.41
1.59
1.7
3.8
32.04
54.85
mg/l
0.84
34
323
54
388
1.41
1.59
1.7
3.8
134.32
70.53
mg/l
0.26
34
321
21
121
1.75
1.58
1.1
1.1
—
—
—
0
0
6
20
3.01
1.58
1.5
1.4
—
—
—
0
0
7
26
2.70
1.58
1.3
1.0
—
—
—
0
0
144
1189
1.23
1.57
2.3
2.8
7.74
10.43
umol/l
1.02
122
1043
34
226
1.52
1.49
1.3
1.3
—
—
—
0
0
12
58
2.08
1.49
1.6
1.1
—
—
—
0
0
12
58
2.08
1.49
1.6
1.1
—
—
—
0
0
12
58
2.08
1.49
1.6
1.1
—
—
—
0
0
12
58
2.08
1.49
1.6
1.1
—
—
—
0
0
12
58
2.08
1.49
1.6
1.1
—
—
—
0
0
754
7095
1.12
1.47
6.0
4.7
5195.57
2349.37
e6/l
0.28
14
121
67
510
1.33
1.41
1.7
1.7
—
—
—
0
0
923
9648
0.89
1.41
6.7
5.9
41.04
40.38
mmol/mol
1.29
828
8787
13
67
1.95
1.38
2.1
1.4
1.39
0.80
promille
—
7
50
5
17
2.95
1.36
1.2
1.2
—
—
—
0
0
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
15
82
1.84
1.35
1.0
1.0
—
—
—
0
0
20
120
1.67
1.34
1.3
1.2
7.44
6.73
u/ml
—
9
33
13
234
0.55
1.34
1.5
1.4
—
—
—
0
0
18
105
1.72
1.33
1.2
1.2
279.00
280.43
mosm/kgh2o
0.08
13
76
53
394
1.36
1.32
3.1
2.2
293.89
566.86
ug/l
1.06
48
370
26
168
1.56
1.32
1.4
1.2
—
—
—
0
0
37
259
1.44
1.30
2.8
2.5
4.04
3.55
g/l
0.89
31
249
12
62
1.94
1.27
1.4
1.1
—
—
—
0
0
37
260
1.43
1.27
1.5
1.5
—
—
—
0
0
36
252
1.44
1.27
1.7
2.0
—
—
—
0
0
172
1479
1.18
1.27
9.1
5.3
1.04
1.03
mmol/l
0.08
159
1355
30
203
1.49
1.25
1.5
1.6
244.12
281.57
mu/l
0.45
24
182
19
115
1.66
1.25
1.6
1.3
509.74
329.01
u/l
0.57
19
108
438
4031
1.12
1.22
4.1
3.3
—
—
—
0
0
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
17
101
1.69
1.20
1.4
1.2
45.83
64.09
u/l
1.13
12
91
24
157
1.54
1.17
1.5
1.2
256.50
277.63
u/ml
0.14
14
89
72
572
1.27
1.15
1.9
1.8
—
—
—
0
0
363
3318
1.12
1.14
3.3
3.1
7.19
7.46
mmol/l
0.52
299
2722
25
169
1.49
1.07
2.2
1.4
120.57
140.88
u/ml
—
7
33
27
188
1.44
1.01
1.4
1.4
10.05
10.20
u/l
0.02
19
147
29
205
1.42
1.01
1.7
1.9
—
—
—
0
0
545
5130
1.10
0.97
4.7
3.8
0.00
0.00
estimate
0.50
148
902
10
54
1.86
0.96
1.0
1.1
—
—
—
0
0
10
54
1.86
0.96
1.6
1.4
—
—
—
0
0
10
54
1.86
0.96
1.6
1.4
—
—
—
0
0
348
3206
1.11
0.96
3.4
3.2
584.12
330.59
mg/l
0.37
231
2054
11
62
1.78
0.94
1.3
1.2
—
85.00
—
0
6
11
62
1.78
0.94
1.5
3.5
109.91
86.21
nmol/l
0.21
11
62
38
286
1.34
0.93
1.2
1.3
—
—
—
0
0
6
27
2.23
0.93
1.3
1.7
—
—
—
0
0
523
4926
1.09
0.91
3.0
2.6
—
—
—
0
0
163
1839
0.87
0.90
3.7
2.8
1.25
1.13
e6/l
0.19
99
1083
16
102
1.57
0.90
1.7
1.3
25.70
27.25
%
—
10
63
8
42
1.91
0.88
1.1
1.2
—
—
—
0
0
8
43
1.86
0.87
1.0
1.0
—
—
—
0
0
20
136
1.48
0.86
3.1
1.9
13817.31
1035.47
u/l
—
8
52
302
2779
1.11
0.85
5.1
4.2
0.00
0.00
estimate
0.69
148
872
114
985
1.17
0.85
1.9
1.8
1.52
1.51
%
0.04
96
850
12
72
1.67
0.85
1.5
1.4
—
—
—
0
0
12
72
1.67
0.85
1.5
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
51
408
1.26
0.83
4.9
2.6
0.40
0.34
u/ml
0.60
36
237
6
32
1.88
0.81
1.8
1.3
24.67
22.39
%
—
6
23
364
3392
1.10
0.80
4.1
3.7
10.02
8.81
mg/mmol
0.19
233
2154
20
139
1.44
0.79
1.6
1.4
78761.69
73009.64
e6/l
0.04
13
77
138
1219
1.14
0.78
3.7
4.0
6.50
22.87
ug/l
1.44
111
997
0
26
0.00
0.78
0.0
1.2
—
1.10
—
0
19
236
2159
1.11
0.76
3.0
3.1
2.48
2.45
mmol/l
2.76
206
1890
157
1751
0.88
0.75
4.0
3.0
2.57
1.89
e6/l
0.55
95
1004
13
195
0.66
0.72
1.5
1.4
—
—
—
0
0
415
3911
1.08
0.71
5.0
4.1
—
—
—
0
0
5
26
1.93
0.70
1.4
1.4
—
—
—
0
0
7
43
1.63
0.67
1.1
1.1
1002.86
228.17
iu/ml
—
7
43
110
970
1.14
0.66
2.2
2.4
30.26
39.46
u/l
1.15
89
816
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
28
1.79
0.66
1.6
1.3
173.60
171.69
%
—
5
28
531
5066
1.07
0.65
6.2
5.1
0.00
0.00
estimate
-0.00
159
936
5
29
1.73
0.64
1.0
1.1
97.60
103.41
%
—
5
22
532
5082
1.07
0.63
4.7
3.8
0.01
0.00
estimate
0.13
165
1018
94
825
1.15
0.62
5.3
3.7
108.61
95.54
ng/l
0.66
77
707
5
30
1.67
0.61
2.0
2.2
—
—
—
0
0
5
30
1.67
0.61
2.0
2.2
—
—
—
0
0
80
695
1.16
0.61
1.9
1.5
—
—
—
0
0
55
466
1.19
0.57
1.9
2.8
—
—
—
0
0
34
274
1.25
0.57
3.3
2.3
42.36
86.74
ug/min
0.94
17
161
28
221
1.27
0.55
1.4
1.7
3.82
5.28
iu/l
—
8
68
915
9369
0.94
0.54
5.5
4.5
1.87
2.14
mu/l
1.29
838
8372
22
169
1.31
0.53
1.6
1.2
—
—
—
0
0
13
91
1.43
0.53
3.7
2.3
864.29
687.11
ml
—
7
57
36
435
0.82
0.52
3.9
3.0
18.17
8964.04
u/ml
0.81
29
376
10
67
1.50
0.49
1.3
1.3
—
—
—
0
0
10
67
1.50
0.49
1.3
1.3
—
—
—
0
0
24
191
1.26
0.46
1.0
1.2
220.85
223.27
miu/ml
—
7
75
11
77
1.43
0.45
3.0
1.2
—
—
u/ml
—
0
0
47
404
1.17
0.44
1.1
1.0
—
—
—
0
0
22
274
0.80
0.43
1.3
1.6
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
15
114
1.32
0.40
2.7
2.9
—
—
—
0
0
30
250
1.20
0.40
1.4
1.7
10230.52
17679.84
e6/l
0.94
25
176
8
60
1.33
0.40
2.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
36
421
0.85
0.39
1.3
1.3
—
—
—
0
0
7
104
0.67
0.39
1.1
1.1
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
17
215
0.79
0.39
1.3
1.4
10.75
45.47
e6/l
0.64
12
172
9
71
1.27
0.36
1.6
1.3
—
—
—
0
0
72
793
0.90
0.34
2.2
2.2
12.16
12.20
nmol/l
0.01
65
698
6
44
1.36
0.34
1.7
1.4
—
—
—
0
0
15
119
1.26
0.31
1.1
1.2
5.20
7.15
u/ml
—
5
53
17
139
1.23
0.29
2.0
1.5
—
—
—
0
0
71
653
1.09
0.27
2.5
2.5
15.63
24.75
au/ml
—
6
39
18
213
0.84
0.25
1.6
1.6
—
—
—
0
0
36
321
1.12
0.24
1.4
1.5
—
—
—
0
0
177
1692
1.05
0.24
2.5
2.0
30.97
29.85
s
1.21
165
1638
7
93
0.75
0.22
1.1
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
2.9
—
65.43
—
0
14
10
82
1.22
0.17
2.1
2.2
—
—
—
0
0
9
79
1.14
0.15
3.9
2.5
13.43
13.19
%
—
9
79
1026
10335
0.98
0.15
26.4
15.0
23.94
26.99
mg/l
2.36
922
8204
14
122
1.15
0.13
1.1
1.0
—
—
—
0
0
27
292
0.92
0.12
1.0
1.1
—
—
—
0
0
274
2690
1.02
0.11
4.5
3.8
85.67
85.53
%
0.03
257
2617
24
259
0.93
0.10
5.7
3.5
20.08
27.53
mg/l
0.79
12
176
56
535
1.05
0.10
1.2
1.2
60.21
143.43
iu/ml
2.20
19
199
5
44
1.14
0.10
1.0
1.3
5.64
6.61
mmol/l
—
5
44
5
45
1.11
0.09
1.0
1.3
—
—
—
0
0
78
807
0.96
0.09
2.9
2.8
61.52
62.34
ml/min/173m2
0.06
29
357
109
1118
0.97
0.08
1.3
1.4
—
—
—
0
0
7
66
1.06
0.08
3.7
1.6
—
—
—
0
0
6
72
0.83
0.07
1.2
2.2
—
116.93
—
0
15
8
75
1.07
0.07
1.6
1.2
—
—
—
0
0
8
78
1.03
0.07
1.4
1.6
—
—
—
0
0
13
118
1.10
0.07
2.2
2.0
1.33
1.89
u/field
—
6
37
23
243
0.95
0.05
1.4
1.3
—
—
—
0
0
58
563
1.03
0.05
1.7
1.7
1.60
1.55
g/l
0.12
49
476
969
9722
0.99
0.05
22.6
14.3
77.37
75.53
ml/min/173m2
1.86
868
8049
28
293
0.95
0.05
1.0
1.1
—
—
—
0
0
18
169
1.07
0.05
1.6
1.8
4.71
4.78
mmol/24h
0.03
18
147
17
161
1.06
0.03
1.1
1.1
—
—
—
0
0
260
2614
0.99
0.02
1.6
1.6
1.49
1.33
mmol/l
1.17
195
2161
135
1345
1.00
0.00
4.7
4.6
32.92
32.76
%
0.05
96
871
13
127
1.02
0.00
1.7
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
4.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
8.18
—
0
5
6
69
0.87
-0.00
2.0
2.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
38.28
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
21.32
—
0
5
6
62
0.97
-0.00
1.3
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
6
62
0.97
-0.00
1.2
2.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
57.86
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
2.60
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint J10_BRONCHNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_BRONCHNAS | 1.856 [1.65, 2.08] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.249 |
During the follow-up period (1.1.1998 — 31.12.2019), 1058 out of 2991 females with J10_BRONCHNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_BRONCHNAS | 2.101 [1.86, 2.37] | < 0.001 |
| Birth year | 0.986 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 1766 out of 3561 males with J10_BRONCHNAS died.
Mortality risk
Mortality risk for people of age
years, who have J10_BRONCHNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.175% | 0.429% |
| 5 | 0.997% | 2.609% |
| 10 | 2.501% | 6.064% |
| 15 | 5.092% | 10.933% |
| 20 | 8.903% | 18.446% |
Relationships between endpoints
↥Index endpoint: J10_BRONCHNAS – Unspecified chronic bronchitis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data